Systemic lupus erythematosus
- 2012 ACR guideline for LN
- 2023 EULAR guideline for SLE
- 2024 ACR guideline for LN
- 2025 EULAR guideline for LN
- 2025 TSOC for secondary hypogammaglobulinemia
- 2025 ACR guideline for SLE：guideline summary
- 2025 ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare SLE manifestations
Rheumatoid arthritis
- 2008 ACR Recommendations for the Use of DMARDs in RA
- 2012 update of 2008 ACR Recommendations for the Use of DMARDs in RA
- 2015 ACR guideline for RA
- 2016 update of EULAR recommendations for the management of RA with DMARDs
- 2017 EULAR definition of arthralgia suspicious for progression to RA
- 2019 update of EULAR recommendations for the management of RA with DMARDs
- 2020 EULAR definition of difficult- to- treat RA
- 2021 ACR guideline for RA
- 2021 EULAR points to consider for the management of difficult- to- treat RA
- 2022 EULAR guideline for RA
- 2022 ACR Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for RA
- 2025 TSOC for secondary hypogammaglobulinemia
Ankylosing spondylitis
- 2019 ACR/SAA/SPARTAN guideline for AS & nr-axSpA
- 2022 ASAS-EULAR guideline for axSpA
- 2024 Updating the 2019 ACR/SAA/SPART guideline for AS & nr-axSpA
- 2025 BSR guideline for axSpA
